Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide

Authors

  • E L Veale,

    1. Medway School of Pharmacy, Universities of Kent and Greenwich at Medway, Kent, UK
    2. Biophysics Section, Blackett Laboratory, Division of Cell and Molecular Biology, Imperial College London, London, UK
    Search for more papers by this author
  • R Buswell,

    1. Biophysics Section, Blackett Laboratory, Division of Cell and Molecular Biology, Imperial College London, London, UK
    Search for more papers by this author
  • C E Clarke,

    1. Victor Chang Research Institute, University of New South Wales, Sydney, Australia
    Search for more papers by this author
  • A Mathie

    Corresponding author
    1. Medway School of Pharmacy, Universities of Kent and Greenwich at Medway, Kent, UK
    2. Biophysics Section, Blackett Laboratory, Division of Cell and Molecular Biology, Imperial College London, London, UK
    Search for more papers by this author

Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Central Avenue, Chatham Maritime, Kent ME4 4TB, UK. E-mail: a.a.mathie@kent.ac.uk

Abstract

Background and purpose:

The TASK subfamily of two pore domain potassium channels (K2P) encodes for leak K currents, contributing to the resting membrane potential of many neurons and regulating their excitability. TASK1 and TASK3 channels are regulated by a number of pharmacological and physiological mediators including cannabinoids such as methanandamide. In this study, we investigate how methanandamide blocks these channels.

Experimental approach:

Currents through wild type and mutated TASK1 and TASK3 channels expressed in modified HEK-293 cells were measured using whole-cell electrophysiological recordings in the presence and absence of methanandamide.

Key results:

Methanandamide (3 μM) produced substantial block of hTASK1, hTASK3 and mTASK3 channels but was most potent at blocking hTASK3 channels. Block of these channels was irreversible unless cells were washed with buffer containing bovine serum albumin. Mutation of the distal six amino acids of TASK1 did not alter methanandamide inhibition, whilst C terminal truncation of TASK3 channels caused a small but significant reduction of inhibition. However, deletion of six amino acids (VLRFLT) at the interface between the final transmembrane domain and cytoplasmic C terminus of TASK3 channels gave functional currents that were no longer inhibited by methanandamide or by activation of GPCRs.

Conclusions and implications:

Methanandamide potently blocked TASK3 and TASK1 channels and both methanandamide and G protein-mediated inhibition converged on the same intracellular gating pathway. Physiologically, methanandamide block of TASK1 and TASK3 channels may underpin a number of CNS effects of cannabinoids that are not mediated through activation of CB1 or CB2 receptors.

British Journal of Pharmacology (2007) 152, 778–786. doi:10.1038/sj.bjp.0707436; published online 10 September 2007

Ancillary